Accès ouvert

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Article scientifique 2024 Anglais

Résumé

In the Introduction, references 23 and 26 were inadvertently omitted in two sentences, and have been added as follows: ‘The Antibody Mediated Prevention (AMP) trials were the first human efficacy studies of infused bnAbs for HIV-1 prevention (HVTN 704/HPTN 085 and HVTN 703/HPTN 081) 23 . The efficacy of a CD4-binding site bnAb, VRC01, was tested in men, women and transgender individuals who were vulnerable to HIV-1 in the Americas, sub-Saharan Africa and Europe 24–26 .’

Citer ce document

Reeves, D., Mayer, B., deCamp, A., Huang, Y., Zhang, B., Carpp, L., Magaret, C., Juraska, M., Gilbert, P., Montefiori, D., Bar, K., Cardozo-Ojeda, E., Schiffer, J., Rossenkhan, R., Edlefsen, P., Morris, L., Mkhize, N., Williamson, C., Mullins, J., Seaton, K., Tomaras, G., Andrew, P., Mgodi, N., Ledgerwood, J., Cohen, M., Corey, L., Naidoo, L., Orrell, C., Goepfert, P., Casapía, M., Sobieszczyk, M., Karuna, S., Edupuganti, S. (2024). Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. https://doi.org/10.1038/s41467-024-46805-8

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Statistiques

Consultations : 1

Téléchargements : 0